Alphatec Holdings Inc.
https://atecspine.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Alphatec Holdings Inc.
EMA Decision Time For Aztreonam-Avibactam; High-Stakes Meeting For Lecanamab
The European Medicines Agency is this week deciding whether a number of new drugs should win EU approval.
Fresenius Divests Norwegian Plant To Prange
Fresenius Kabi has completed the divestment of a manufacturing plant in Halden, Norway, to Prange Group.
Fresenius Claims Edge With US Tocilizumab Biosimilar Approval
Fresenius Kabi has claimed an advantage in the biosimilar tocilizumab arena after its Tyenne rival to Actemra was approved by the US FDA in both intravenous and subcutaneous formulations.
Bespoke Gene Therapy ‘Playbook’ Outlines Platform Approach To AAV-Based Treatments
Supporting ‘n of 1’ gene therapy development, the playbook from a Foundation for the National Institutes of Health-backed consortium aims to help investigators who are not traditional product sponsors prepare for meetings with US FDA and IND submissions.
Company Information
- Industry
-
Medical Devices
- Implantable Devices
- Surgical Equipment & Devices
- Other Names / Subsidiaries
-
- Alphatec Spine, Inc.
- Atec Spine
- SafeOp Surgical
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice